1. Home
  2. CDIO vs SLE Comparison

CDIO vs SLE Comparison

Compare CDIO & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • SLE
  • Stock Information
  • Founded
  • CDIO 2017
  • SLE 2014
  • Country
  • CDIO United States
  • SLE United States
  • Employees
  • CDIO N/A
  • SLE N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • CDIO Health Care
  • SLE Consumer Discretionary
  • Exchange
  • CDIO Nasdaq
  • SLE Nasdaq
  • Market Cap
  • CDIO 7.0M
  • SLE 6.5M
  • IPO Year
  • CDIO N/A
  • SLE 2019
  • Fundamental
  • Price
  • CDIO $4.77
  • SLE $0.13
  • Analyst Decision
  • CDIO Buy
  • SLE Strong Buy
  • Analyst Count
  • CDIO 1
  • SLE 2
  • Target Price
  • CDIO $60.00
  • SLE $2.50
  • AVG Volume (30 Days)
  • CDIO 102.5K
  • SLE 14.5M
  • Earning Date
  • CDIO 05-15-2025
  • SLE 05-15-2025
  • Dividend Yield
  • CDIO N/A
  • SLE N/A
  • EPS Growth
  • CDIO N/A
  • SLE N/A
  • EPS
  • CDIO N/A
  • SLE N/A
  • Revenue
  • CDIO $19,902.00
  • SLE $14,691,000.00
  • Revenue This Year
  • CDIO $1,434.82
  • SLE N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • SLE $30.36
  • P/E Ratio
  • CDIO N/A
  • SLE N/A
  • Revenue Growth
  • CDIO N/A
  • SLE N/A
  • 52 Week Low
  • CDIO $3.40
  • SLE $0.12
  • 52 Week High
  • CDIO $53.10
  • SLE $1.64
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 39.92
  • SLE 37.97
  • Support Level
  • CDIO $3.88
  • SLE $0.12
  • Resistance Level
  • CDIO $5.20
  • SLE $0.29
  • Average True Range (ATR)
  • CDIO 0.48
  • SLE 0.04
  • MACD
  • CDIO 0.32
  • SLE -0.00
  • Stochastic Oscillator
  • CDIO 68.25
  • SLE 5.39

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: